TY - JOUR
T1 - Investigating the Added Value of Beck's Depression Inventory in Atherosclerosis Prediction
T2 - Lessons from Paracelsus 10,000
AU - Dienhart, Christiane
AU - Aigner, Elmar
AU - Iglseder, Bernhard
AU - Frey, Vanessa
AU - Gostner, Isabella
AU - Langthaler, Patrick
AU - Paulweber, Bernhard
AU - Trinka, Eugen
AU - Wernly, Bernhard
N1 - Dienhart, Aigner, Paulweber: Department of Internal Medicine I, Paracelsus Medical University, 5020 Salzburg, Austria; Iglseder: Department of Geriatric Medicine, Christian Doppler University Hospital, Paracelsus Medical University; Frey, Gostner, Langthaler, Trinka: Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University and Centre for Cognitive Neuroscience, Affiliated Member of the European Reference Network EpiCARE, 5020 Salzburg, Austria; Langthaler: eam Biostatistics and Big Medical Data, IDA Lab Salzburg, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria; Trinka: Neuroscience Institute, Christian Doppler University Hospital, Paracelsus Medical University and Centre for Cognitive Neuroscience, Affiliated Member of the European Reference Network EpiCARE, 5020 Salzburg, Austria; Paulweber: Obesity Research Unit, Paracelsus Medical University, 5020 Salzburg, Austria; Wernly: Department of Internal Medicine I, Oberndorf Hospital, 5110 Salzburg, Austria; Institute for General and Preventive Medicine, Paracelsus Medical University, 5020 Salzburg, Austria
(Gosner ist nicht identizierbar, daher konnte ich sie keine interne OE zuordnen)
PY - 2024/8
Y1 - 2024/8
N2 -
Background: Depression is the most common mental illness worldwide and generates an enormous health and economic burden. Furthermore, it is known to be associated with an elevated risk of arteriosclerotic cardiovascular diseases (ASCVD), particularly stroke. However, it is not a factor reflected in many ASCVD risk models, including SCORE2. Thus, we analysed the relationship between depression, ASCVD and SCORE2 in our cohort.
Methods: We analysed 9350 subjects from the Paracelsus 10,000 cohort, who underwent both a carotid artery ultrasound and completed a Beck Depression Inventory (BDI) screening. Patients were categorised binomially based on the BDI score. Atherosclerotic carotid plaque or absence was dichotomised for logistic regression modelling. Odds ratios and adjusted relative risks were calculated using Stata.
Results: Subjects with an elevated BDI (≥14) had higher odds for carotid plaques compared to subjects with normal BDI, especially after adjusting for classical risk factors included in SCORE2 (1.21; 95%CI 1.03-1.43,
p = 0.023). The adjusted relative risk for plaques was also increased (1.09; 95%CI 1.01-1.18,
p = 0.021). Subgroup analysis showed an increased odds of plaques with increases in depressive symptoms, particularly in women and patients ≤55 yrs.
Conclusions: In our cohort, the BDI score is associated with subclinical atherosclerosis beyond classical risk factors. Thus, depression might be an independent risk factor which may improve risk stratification if considered in ASCVD risk prediction models, such as SCORE2. Furthermore, reminding clinicians to take mental health into consideration to identify individuals at increased atherosclerosis risk may provide added opportunities to address measures which can reduce the risk of ASCVD.
AB -
Background: Depression is the most common mental illness worldwide and generates an enormous health and economic burden. Furthermore, it is known to be associated with an elevated risk of arteriosclerotic cardiovascular diseases (ASCVD), particularly stroke. However, it is not a factor reflected in many ASCVD risk models, including SCORE2. Thus, we analysed the relationship between depression, ASCVD and SCORE2 in our cohort.
Methods: We analysed 9350 subjects from the Paracelsus 10,000 cohort, who underwent both a carotid artery ultrasound and completed a Beck Depression Inventory (BDI) screening. Patients were categorised binomially based on the BDI score. Atherosclerotic carotid plaque or absence was dichotomised for logistic regression modelling. Odds ratios and adjusted relative risks were calculated using Stata.
Results: Subjects with an elevated BDI (≥14) had higher odds for carotid plaques compared to subjects with normal BDI, especially after adjusting for classical risk factors included in SCORE2 (1.21; 95%CI 1.03-1.43,
p = 0.023). The adjusted relative risk for plaques was also increased (1.09; 95%CI 1.01-1.18,
p = 0.021). Subgroup analysis showed an increased odds of plaques with increases in depressive symptoms, particularly in women and patients ≤55 yrs.
Conclusions: In our cohort, the BDI score is associated with subclinical atherosclerosis beyond classical risk factors. Thus, depression might be an independent risk factor which may improve risk stratification if considered in ASCVD risk prediction models, such as SCORE2. Furthermore, reminding clinicians to take mental health into consideration to identify individuals at increased atherosclerosis risk may provide added opportunities to address measures which can reduce the risk of ASCVD.
U2 - 10.3390/jcm13154492
DO - 10.3390/jcm13154492
M3 - Original Article
C2 - 39124759
SN - 2077-0383
VL - 13
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 15
M1 - 4492
ER -